EtiraRx Company Profile
EtiraRx, founded in 2018 and based in Dallas, TX, is a privately held biopharma research company with 4 employees that develops novel cancer therapeutics targeting tumor heterogeneity and therapy resistance, has raised over $9 million through venture capital and government grants including a recent $2.28M later-stage VC round in 2026, and is backed by the National Cancer Institute.
Company Overview
Year Founded: 2018
Status: Private
Employees: 4
Latest Deal Type: Later Stage VC
Latest Deal Amount: $2.28M
Investors: 1
Description
EtiraRx is a biopharma research company focused on developing products to overcome tumor heterogeneity. The company advances novel cancer therapeutics, validating molecular drivers of cancers to lead a systemic evaluation of mechanisms of therapy resistance and to the development of novel therapeutics to treat cancers. This enables patients to plan for a future with previously untreatable cancers.
Contact Information
- Website: www.etira.life
- Corporate Office: 3060 Pegasus Park Drive, Dallas, TX 75247, United States
- Phone: +1 (469)
- Social: LinkedIn, Twitter, Facebook
Ownership Status: Privately Held (backing)
Financing Status: Venture Capital-Backed
Primary Industry: Drug Discovery
Other Industries: Biotechnology
Verticals: Life Sciences, Oncology
Valuation & Funding
- Deal 4: Later Stage VC, 13-May-2026, $2.28M, Completed, Clinical Trials - Phase 1
- Deal 3: Later Stage VC, 23-Jun-2025, Completed, Clinical Trials - Phase 1
- Deal 2: Later Stage VC, 05-Oct-2023, $4.82M, $4.82M raised to date, Completed, Clinical Trials - Phase 1
- Deal 1: Grant, 20-Aug-2021, $2M, Completed, Pre-Clinical Trials
Cap Table (Partial)
- Series A-1B: 1,298,043 shares, Par Value: $0.000010, Original Issue Price: $1.98, Liquidation: $1.98, Liquidation Pref. Multiple: 1x, Conversion Price: $1.98, % Owned: 6.78%
- Series A-1A: 961,531 shares, Par Value: $0.000010, Original Issue Price: $2.47, Liquidation: $2.47, Liquidation Pref. Multiple: 1x, Conversion Price: $2.47, % Owned: 5.02%
Investors
- National Cancer Institute (Government)
FAQs
When was EtiraRx founded?
EtiraRx was founded in 2018.
Where is EtiraRx headquartered?
EtiraRx is headquartered in Dallas, TX.
What is the size of EtiraRx?
EtiraRx has 4 total employees.
What industry is EtiraRx in?
EtiraRx’s primary industry is Drug Discovery.
Is EtiraRx a private or public company?
EtiraRx is a Private company.
How much funding has EtiraRx raised over time?
EtiraRx has raised $9.5M.
Who are EtiraRx’s investors?
National Cancer Institute has invested in EtiraRx.